Hybrid Graphene Oxide Based Plasmonic-Magnetic Multifunctional Nanoplatform for Selective Separation and Label-Free Identification of Alzheimer’s Disease Biomarkers
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Despite intense efforts, Alzheimer's disease (AD) is one of the top public health crisis for society even at 21st century. Since presently there is no cure for AD, early diagnosis of possible AD biomarkers is crucial for the society. Driven by the need, the current manuscript reports the development of magnetic core-plasmonic shell nanoparticle attached hybrid graphene oxide based multifunctional nanoplatform which has the capability for highly selective separation of AD biomarkers from whole blood sample, followed by label-free surface enhanced Raman spectroscopy (SERS) identification in femto gram level. Experimental ELISA data show that antibody-conjugated nanoplatform has the capability to capture more than 98% AD biomarkers from the whole blood sample. Reported result shows that nanoplatform can be used for SERS "fingerprint" identification of β-amyloid and tau protein after magnetic separation even at 100 fg/mL level. Experimental results indicate that very high sensitivity achieved is mainly due to the strong plasmon-coupling which generates huge amplified electromagnetic fields at the "hot spot". Experimental results with nontargeted HSA protein, which is one of the most abundant protein components in cerebrospinal fluid (CSF), show that multifunctional nanoplatform based AD biomarkers separation and identification is highly selective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Raman spectroscopy as a versatile tool for studying the properties of graphene
Ferrari, A. C., & Basko, D. M. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.46 · Cited by 7,405
Wu, Z.-S., Yang, S., Sun, Y., Parvez, K., Feng, X., & Müllen, K. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3030565 · Cited by 2,061
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Blennow, K., Hampel, H., Weiner, M., & Zetterberg, H. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.4 · Cited by 1,863 · cited 8×
“clearly indicate that the β amyloid (1-42) separation efficiency is less than 3% when anti- β amyloid antibody was not conjugated with nanoplatform.”
InfluentialClassification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Ray, S., Britschgi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., Blennow, K., Friedman, L. F., Galasko, D. R., Jutel, M., Karydas, A., et al. (2007) · Nature Medicine · doi:10.1038/nm1653 · Cited by 1,048 · cited 8×
“clearly indicate that the β amyloid (1-42) separation efficiency is less than 3% when anti- β amyloid antibody was not conjugated with nanoplatform.”
InfluentialTiwari, S. K., Agarwal, S., Seth, B., Yadav, A., Nair, S., Bhatnagar, P., Karmakar, M., Kumari, M., Chauhan, L. K. S., Patel, D. K., et al. (2014) · ACS Nano · doi:10.1021/nn405077y · Cited by 558 · cited 8×
“clearly indicate that the β amyloid (1-42) separation efficiency is less than 3% when anti- β amyloid antibody was not conjugated with nanoplatform.”
InfluentialUsing Graphene Oxide High Near‐Infrared Absorbance for Photothermal Treatment of Alzheimer's Disease
Li, M., Yang, X., Ren, J., Qu, K., & Qu, X. (2012) · Advanced Materials · doi:10.1002/adma.201104864 · Cited by 535
The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease
Ferreira, S. T., & Klein, W. L. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.08.003 · Cited by 442 · cited 8×
“clearly indicate that the β amyloid (1-42) separation efficiency is less than 3% when anti- β amyloid antibody was not conjugated with nanoplatform.”
InfluentialSensitive ELISA detection of amyloid‐β protofibrils in biological samples
Englund, H., Sehlin, D., Johansson, A., Nilsson, L. N. G., Gellerfors, P., Paulie, S., Lannfelt, L., & Pettersson, F. E. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04759.x · Cited by 292
Cited by
Nanoparticle-Based Immunochemical Biosensors and Assays: Recent Advances and Challenges
Farka, Z., Juřík, T., Kovář, D., Trnková, L., & Skládal, P. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00037 · Cited by 694
Graphene oxide: strategies for synthesis, reduction and frontier applications
Singh, R. K., Kumar, R., & Singh, D. P. (2016) · RSC Advances · doi:10.1039/c6ra07626b · Cited by 626
Recent advances in graphene-based biosensor technology with applications in life sciences
Peña-Bahamonde, J., Nguyen, H. N., Fanourakis, S. K., & Rodrigues, D. F. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0400-z · Cited by 545
Su, C. (2017) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2016.06.060 · Cited by 365
Singh, D. P., Herrera, C. E., Singh, B., Singh, S., Singh, R. K., & Kumar, R. (2018) · Materials Science and Engineering: C · doi:10.1016/j.msec.2018.01.004 · Cited by 313
Graphene-Based Biosensors for Detection of Biomarkers
Bai, Y., Xu, T., & Zhang, X. (2020) · Micromachines · doi:10.3390/mi11010060 · Cited by 273
Superparamagnetic nanoarchitectures for disease-specific biomarker detection
Masud, M. K., Na, J., Younus, M., Hossain, M. S. A., Bando, Y., Shiddiky, M. J. A., & Yamauchi, Y. (2019) · Chemical Society Reviews · doi:10.1039/c9cs00174c · Cited by 257
Kim, K., Kim, M.-J., Kim, D. W., Kim, S. Y., Park, S., & Park, C. B. (2020) · Nature Communications · doi:10.1038/s41467-019-13901-z · Cited by 255
Graphene quantum dots conjugated neuroprotective peptide improve learning and memory capability
Xiao, S., Zhou, D., Luan, P., Gu, B., Feng, L., Fan, S., Liao, W., Fang, W., Yang, L., Tao, E., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.08.021 · Cited by 169
Current trends in blood biomarker detection and imaging for Alzheimer’s disease
Hu, S., Yang, C., & Luo, H. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114278 · Cited by 84
Bertorelle, F., Pinto, M., Zappon, R., Pilot, R., Litti, L., Fiameni, S., Conti, G., Gobbo, M., Toffoli, G., Colombatti, M., et al. (2018) · Nanoscale · doi:10.1039/c7nr07844g · Cited by 34
Sun, L., Liu, D., Fu, D., Yue, T., Scharre, D., & Zhang, L. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.126733 · Cited by 32
Progress and challenges in the diagnosis of dementia: a critical review
Paraskevaidi, M., Martin-Hirsch, P. L., & Martin, F. L. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00007 · Cited by 31
Nanotechnology in the diagnostic and therapy for Alzheimer's disease
Panghal, A., & Flora, S. J. S. (2024) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2024.130559 · Cited by 31
Unveiling the theranostic potential of SPIONs in Alzheimer's disease management
Aminyavari, S., Afshari, A. R., Ahmadi, S. S., Kesharwani, P., Sanati, M., & Sahebkar, A. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.09.022 · Cited by 5
Metadata
- Authors
- Demeritte, T., Viraka Nellore, B. P., Kanchanapally, R., Sinha, S. S., Pramanik, A., Chavva, S. R., & Ray, P. C.
- Venue
- ACS Applied Materials & Interfaces
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-06-09
- Volume
- 7
- Issue
- 24
- Pages
- 13693-13700
- ISSN
- 1944-8244 (ISSN-L)
- 1944-8252
- OpenAlex
- W637675486
- Cited by
- 154
- References
- 8
- FWCI
- 4.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.